Article(id=1325223695517627239, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223620166943241, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2026.05.016, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1756742400000, receivedDateStr=2025-09-02, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887550477, onlineDateStr=2026-11-05, pubDate=1778342400000, pubDateStr=2026-05-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887550477, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887550477, creator=13701087609, updateTime=1793887550477, updator=13701087609, issue=Issue{id=1325223620166943241, tenantId=1146029695717560320, journalId=1319690329412173987, year='2026', volume='47', issue='5', pageStart='455', pageEnd='588', issueExtLink='null', onlineDate='null', pubDate='1778342400000', pubDateStr='2026-05-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887532512, creator='13701087609', updateTime=1793934786637, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325421818395361842, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223620166943241, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325421818395361843, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223620166943241, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=560, endPage=567, ext={EN=ArticleExt(id=1325223696268407656, articleId=1325223695517627239, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Mesenchymal stem cells and extracellular vesicles: multidimensional therapeutic mechanisms and engineered breakthroughs targeting pulmonary fibrosis, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Pulmonary fibrosis is a chronic progressive interstitial lung disease induced by multiple factors such as environmental exposure, infections. Its core pathological features are abnormal extracellular matrix deposition and myofibroblast over-activation. The efficacy of currently available therapeutic agents is limited, as they lack sufficient targeting capacity and are unable to reverse the progression of fibrosis. In recent years, pluripotent mesenchymal stem cells(MSCs) and their secreted extracellular vesicles(especially exosomes) have shown breakthrough potential in the treatment of pulmonary fibrosis due to their unique tissue repair and immunomodulatory functions. This article systematically reviewed the multidimensional antifibrotic mechanisms of MSCs and their extracellular vesicles(exosomes), deeply explored the engineered modification strategies(such as gene modification, novel vectors and delivery systems, and combined interventions) in enhancing therapeutic efficacy, and analyzed the challenges of translating from basic research to the clinic,in order to provide theoretical basis for the research of new anti-fibrosis drugs and the clinical application of MSCs.

, authors=Weili FENG1, 2, 3, Li LIU1, 2, 3, Yifang DENG1, 2, 3, *, authorsList=Weili FENG, Li LIU, Yifang DENG, authorCompany=null, correspAuthors=Yifang DENG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325223696515871593, articleId=1325223695517627239, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=间充质干细胞及细胞外囊泡:靶向肺纤维化的多维治疗机制及工程化突破, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

肺纤维化是一种由环境暴露及感染等多因素诱发的慢性进行性间质性肺病,其核心病理特征表现为细胞外基质异常沉积及肌成纤维细胞过度活化。现有治疗药物因靶向性不足且无法逆转纤维化进程,故疗效有限。近年来,多能间充质干细胞及其分泌的细胞外囊泡(尤其是外泌体)凭借其独特的组织修复及免疫调节功能,在肺纤维化治疗领域展现出突破性潜力。该文系统阐述间充质干细胞及其细胞外囊泡(外泌体)的多维抗纤维化机制,同时深入探讨工程化修饰策略(如基因修饰、新型载体和递送系统以及联合干预)对疗效的提升作用,并分析从基础研究向临床转化面临的挑战,以期为新型抗纤维化药物的研究及间充质干细胞的临床应用提供理论依据。

, authors=冯伟莉1, 2, 3, 刘莉1, 2, 3, 邓轶方1, 2, 3, *, authorsList=冯伟莉, 刘莉, 邓轶方, authorCompany=null, correspAuthors=邓轶方, authorNote=

冯伟莉,硕士研究生,研究方向:药物临床前药效学研究及机制研究。

, correspAuthorsNote=
邓轶方,副研究员,硕士生导师,研究方向:药物研发、成药性评价、临床前药效学研究及机制研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=+XnQ7HLmSzWJJL5BnZi20g==, magXml=icjehc9RzgKAdqJ2zywAOw==, pdfUrl=null, pdf=36vGCD7oZgcrZg7P9iTMfA==, pdfFileSize=966883, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=Wa0LE2+N++0EhMWr0ym60Q==, mapNumber=null, fund=null)}, authors=[Author(id=1325223697069519732, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223697207931768, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, authorId=1325223697069519732, language=EN, stringName=Weili FENG, firstName=Weili, middleName=null, lastName=FENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China
2.National Key Laboratory of Pharmacogenicity Research of Pioneers, Shanghai 200437, China
3.Shanghai Professional and Technical Service Center for Biological Material Drug-Ability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223697275040633, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, authorId=1325223697069519732, language=CN, stringName=冯伟莉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.中国医药工业研究总院,上海 201203
2.先导物成药性研究全国重点实验室,上海 200437
3.上海市生物物质成药性评价技术服务平台,上海 200437, bio={"content":"

冯伟莉,硕士研究生,研究方向:药物临床前药效学研究及机制研究。

"}, bioImg=null, bioContent=

冯伟莉,硕士研究生,研究方向:药物临床前药效学研究及机制研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223696805278570, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=1., ext=[AuthorCompanyExt(id=1325223696809472875, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696805278570, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1325223696817861484, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696805278570, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325223696897553261, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=2., ext=[AuthorCompanyExt(id=1325223696905941870, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696897553261, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Laboratory of Pharmacogenicity Research of Pioneers, Shanghai 200437, China), AuthorCompanyExt(id=1325223696910136175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696897553261, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.先导物成药性研究全国重点实验室,上海 200437)]), AuthorCompany(id=1325223696985633648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=3., ext=[AuthorCompanyExt(id=1325223696989827953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696985633648, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Professional and Technical Service Center for Biological Material Drug-Ability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1325223697002410866, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696985633648, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海市生物物质成药性评价技术服务平台,上海 200437)])]), Author(id=1325223697350538107, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223697447007103, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, authorId=1325223697350538107, language=EN, stringName=Li LIU, firstName=Li, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China
2.National Key Laboratory of Pharmacogenicity Research of Pioneers, Shanghai 200437, China
3.Shanghai Professional and Technical Service Center for Biological Material Drug-Ability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223697598002048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, authorId=1325223697350538107, language=CN, stringName=刘莉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.中国医药工业研究总院,上海 201203
2.先导物成药性研究全国重点实验室,上海 200437
3.上海市生物物质成药性评价技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223696805278570, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=1., ext=[AuthorCompanyExt(id=1325223696809472875, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696805278570, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1325223696817861484, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696805278570, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325223696897553261, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=2., ext=[AuthorCompanyExt(id=1325223696905941870, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696897553261, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Laboratory of Pharmacogenicity Research of Pioneers, Shanghai 200437, China), AuthorCompanyExt(id=1325223696910136175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696897553261, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.先导物成药性研究全国重点实验室,上海 200437)]), AuthorCompany(id=1325223696985633648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=3., ext=[AuthorCompanyExt(id=1325223696989827953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696985633648, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Professional and Technical Service Center for Biological Material Drug-Ability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1325223697002410866, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696985633648, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海市生物物质成药性评价技术服务平台,上海 200437)])]), Author(id=1325223697929352066, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223699074397062, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, authorId=1325223697929352066, language=EN, stringName=Yifang DENG, firstName=Yifang, middleName=null, lastName=DENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, *, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China
2.National Key Laboratory of Pharmacogenicity Research of Pioneers, Shanghai 200437, China
3.Shanghai Professional and Technical Service Center for Biological Material Drug-Ability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223699187643271, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, authorId=1325223697929352066, language=CN, stringName=邓轶方, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, *, address=1.中国医药工业研究总院,上海 201203
2.先导物成药性研究全国重点实验室,上海 200437
3.上海市生物物质成药性评价技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223696805278570, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=1., ext=[AuthorCompanyExt(id=1325223696809472875, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696805278570, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1325223696817861484, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696805278570, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325223696897553261, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=2., ext=[AuthorCompanyExt(id=1325223696905941870, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696897553261, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Laboratory of Pharmacogenicity Research of Pioneers, Shanghai 200437, China), AuthorCompanyExt(id=1325223696910136175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696897553261, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.先导物成药性研究全国重点实验室,上海 200437)]), AuthorCompany(id=1325223696985633648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=3., ext=[AuthorCompanyExt(id=1325223696989827953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696985633648, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Professional and Technical Service Center for Biological Material Drug-Ability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1325223697002410866, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696985633648, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海市生物物质成药性评价技术服务平台,上海 200437)])])], keywords=[Keyword(id=1325223699288306568, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, language=EN, orderNo=1, keyword=mesenchymal stem cells), Keyword(id=1325223699388969865, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, language=EN, orderNo=2, keyword=extracellular vesicles), Keyword(id=1325223699472855946, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, language=EN, orderNo=3, keyword=exosomes), Keyword(id=1325223699598685067, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, language=EN, orderNo=4, keyword=pulmonary fibrosis), Keyword(id=1325223699707736972, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, language=EN, orderNo=5, keyword=engineering modifications), Keyword(id=1325223699791623053, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, language=CN, orderNo=1, keyword=间充质干细胞), Keyword(id=1325223699896480654, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, language=CN, orderNo=2, keyword=细胞外囊泡), Keyword(id=1325223699980366735, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, language=CN, orderNo=3, keyword=外泌体), Keyword(id=1325223700068447120, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, language=CN, orderNo=4, keyword=肺纤维化), Keyword(id=1325223700148138897, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, language=CN, orderNo=5, keyword=工程化修饰)], refs=[Reference(id=1325223700395602835, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=JIANG MN, BU WX, WANG XH, et al. Pulmonary fibrosis:from mechanisms to therapies[J]. J Transl Med, 2025, 23(1):515., articleTitle=null, refAbstract=null), Reference(id=1325223700471100308, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=HAO MJ, GUAN ZJ, ZHANG ZK, et al. Atractylodinol prevents pulmonary fibrosis through inhibiting TGF-β receptor 1 recycling by stabilizing vimentin[J]. Mol Ther,2023, 31(10): 3015-3033., articleTitle=null, refAbstract=null), Reference(id=1325223700840199061, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=ClUA-FERRE L, SUAU R, VANO-SEGARRA I, et al.Therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles: a focus on inflammatory bowel disease[J]. Clin Transl Med, 2024, 14(11): e70075., articleTitle=null, refAbstract=null), Reference(id=1325223700957639574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=GOLMOHAMMADI M, SHEIKHHA MH, GANJI F, et al.Human fetal lung mesenchymal stem cells ameliorate lung injury in an animal model[J]. Sci Rep, 2025, 15(1): 6433., articleTitle=null, refAbstract=null), Reference(id=1325223701326738327, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=ATTIA SH, SAADAWY SF, EL-MAHROKY SM, et al. Alleviation of pulmonary fibrosis by the dual PPAR agonist saroglitazar and breast milk mesenchymal stem cells via modulating TGF-β/SMAD pathway[J]. Naunyn Schmiedebergs Arch Pharmacol, 2024, 397(8): 5953-5974., articleTitle=null, refAbstract=null), Reference(id=1325223701708419992, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU JX, ZHAO LP, LI CS, et al. Mesenchymal stem cell treatment alleviates seawater drowning induced lung injury by inhibiting the TNF-α/Snail/EMT pathway[J]. J Thorac Dis, 2024, 16(11): 7836-7852., articleTitle=null, refAbstract=null), Reference(id=1325223701821666201, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=XIE YY, YI Q, XU CW, et al. Identifying TNFSF4low-MSCs superiorly treating idiopathic pulmonary fibrosis through Tregs differentiation modulation[J]. Stem Cell Res Ther,2025, 16(1): 194., articleTitle=null, refAbstract=null), Reference(id=1325223702132044698, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=DUAN R, HONG CG, WANG X, et al. Olfactory mucosa mesenchymal stem cells alleviate pulmonary fibrosis via the immunomodulation and reduction of inflammation[J]. Bio Med Central Pulm Med, 2024, 24(1): 14., articleTitle=null, refAbstract=null), Reference(id=1325223702228513692, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=CHOI SM, MO Y, BANG JY, et al. Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis[J]. Respir Res, 2023, 24(1): 68., articleTitle=null, refAbstract=null), Reference(id=1325223702547280797, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=LEE H, JEONG OY, PARK HJ, et al. Promising therapeutic effects of embryonic stem cells-origin mesenchymal stem cells in experimental pulmonary fibrosis models: Immunomodulatory and anti-apoptotic mechanisms[J].Immune Netw, 2023, 23(6): e45., articleTitle=null, refAbstract=null), Reference(id=1325223702622778270, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=XU W, LI CK, YANG LS, et al. Immune response regulation by transduced mesenchymal stem cells with decorin gene on bleomycin-induced lung injury, fibrosis, and inflammation[J].Allergol Immunopathol(Madr), 2024, 52(4): 53-59., articleTitle=null, refAbstract=null), Reference(id=1325223703000265631, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=LI M, LI J, WANG Y, et al. Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis[J]. Stem Cell Res Ther, 2024,15(1): 475., articleTitle=null, refAbstract=null), Reference(id=1325223703394530208, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=HOU L, ZHU ZH, JIANG FY, et al. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles alleviated silica induced lung inflammation and fibrosis in mice via circPWWP2A/miR-223-3p/NLRP3 axis[J].Ecotoxicol Environ Saf, 2023, 251: 114537., articleTitle=null, refAbstract=null), Reference(id=1325223703478416289, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=LIANG XP, LI YH, WU YL, et al. Human umbilical cord mesenchymal stem cell-derived microvesicles alleviate pulmonary fibrosis by inhibiting monocyte-macrophage migration through ERK1/2 signaling-mediated suppression of CCL2 expression[J]. Stem Cell Res Ther, 2025, 16(1):145., articleTitle=null, refAbstract=null), Reference(id=1325223703562302370, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=GAO Y, LIU MF, LI Y, et al. Mesenchymal stem cells-extracellular vesicles alleviate pulmonary fibrosis by regulating immunomodulators[J]. World J Stem Cells, 2024,16(6): 670-689., articleTitle=null, refAbstract=null), Reference(id=1325223703658771363, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN F, CHEN ZD, WU HT, et al. Mesenchymal stem cell-derived exosomes attenuate murine cytomegalovirus-infected pneumonia via NF-κB/NLRP3 signaling pathway[J].Viruses, 2024, 16(4): 619., articleTitle=null, refAbstract=null), Reference(id=1325223703792989092, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN W, PENG J, TANG XY, et al. MSC-derived exosome ameliorates pulmonary fibrosis by modulating NOD 1/NLRP3-mediated epithelial-mesenchymal transition and inflammation[J]. Heliyon, 2025, 11(2): e41436., articleTitle=null, refAbstract=null), Reference(id=1325223703885263781, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=ELLIOT SJ, ANDERSON-TERHUNE D, ROOS B,et al. Ratio of miRNA-29 to miRNA-199 expression coordinates mesenchymal stem cell repair of bleomycin-induced pulmonary injury[J]. Mol Ther Nucl Acids, 2025,doi:10.1016/j.omtn.2025.102461., articleTitle=null, refAbstract=null), Reference(id=1325223703994315686, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAO X, WU JY, YUAN RY, et al. Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis[J]. Sci Rep, 2021,doi:10.21203/rs.3.rs-977764/v1., articleTitle=null, refAbstract=null), Reference(id=1325223704069813159, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHI YF, SHU MH, TANG PS, et al. Overexpression of decorin optimizes the treatment efficacy of umbilical cord mesenchymal stem cells in bleomycin-induced pulmonary fibrosis in rats[J]. Stem Cells Int, 2025, 2025(1): 6324980., articleTitle=null, refAbstract=null), Reference(id=1325223704187253672, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU W, WANG J, DING L, et al. Autophagy inhibition enhances antifibrotic potential of placental mesenchymal stem cells of fetal origin via regulating TGF-β1 mediated protein degradation of HGF[J]. Sci Rep, 2025, 15(1): 13805., articleTitle=null, refAbstract=null), Reference(id=1325223704283722665, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=OUJI-SAGESHIMA N, HIYAMA A, KUMAMOTO M, et al.Adipose-derived mesenchymal stem cells(ADSCs) have antifibrotic effects on lung fibroblasts from idiopathic pulmonary fibrosis(IPF) patients[J]. Cells, 2024, 13(24): 2050., articleTitle=null, refAbstract=null), Reference(id=1325223704384385962, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN QH, ZHANG Y, GU X, et al. Microvesicles derived from mesenchymal stem cells inhibit acute respiratory distress syndrome-related pulmonary fibrosis in mouse partly through hepatocyte growth factor[J]. World J Stem Cells,2024, 16(8): 811-823., articleTitle=null, refAbstract=null), Reference(id=1325223704485049259, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG WY, WEN L, DU L, et al. S-RBD-modified and miR-486-5p-engineered exosomes derived from mesenchymal stem cells suppress ferroptosis and alleviate radiation-induced lung injury and long-term pulmonary fibrosis[J]. J Nanobiotechnol, 2024, 22(1): 662., articleTitle=null, refAbstract=null), Reference(id=1325223704577323948, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=CAI LY, WANG J, YI X, et al. Nintedanib-loaded exosomes from adipose-derived stem cells inhibit pulmonary fibrosis induced by bleomycin[J]. Pediatr Res, 2024, 95(6): 1543-1552., articleTitle=null, refAbstract=null), Reference(id=1325223704661210029, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=XIAO K, LIU C, WANG HM, et al. Umbilical cord mesenchymal stem cells overexpressing CXCR7 facilitate treatment of ARDS-associated pulmonary fibrosis via inhibition of Notch/Jag1 mediated by the Wnt/β-catenin pathway[J]. Biomed Pharmacothery, 2023, 165: 115124., articleTitle=null, refAbstract=null), Reference(id=1325223704766067630, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=JIANG QY, NING FA, JIA QY, et al. MiR-148a-3p loaded human umbilical cord mesenchymal stem cell-derived extracellular vesicles alleviates silica-induced pulmonary fibrosis by inhibiting β-catenin signaling[J]. Int J Nanomedicine, 2025, 20: 4319-4336., articleTitle=null, refAbstract=null), Reference(id=1325223704883508143, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=QIU HJ, ZHANG R, SI DZ, et al. Human umbilical cord-mesenchymal stem cells combined with low dosage nintedanib rather than using alone mitigates pulmonary fibrosis in mice[J]. Stem Cells Int, 2025, 2025(1): 9445735., articleTitle=null, refAbstract=null), Reference(id=1325223705030308784, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG YY, LIU C, WANG NX, et al. hAMSCs regulate EMT in the progression of experimental pulmonary fibrosis through delivering miR-181a-5p targeting TGFBR1[J]. Stem Cell Res Ther, 2025, 16(1): 2., articleTitle=null, refAbstract=null), Reference(id=1325223705185498033, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=HAN MM, HE XY, TANG L, et al. Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice[J]. Sci Adv, 2023, 9(29): eadg5358., articleTitle=null, refAbstract=null), Reference(id=1325223705277772722, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=CHU KA, YEH CC, HSU CH, et al. Reversal of pulmonary fibrosis: human umbilical mesenchymal stem cells from Wharton's jelly versus human-adipose-derived mesenchymal stem cells[J]. Int J Mol Sci, 2023, 24(8): 6948., articleTitle=null, refAbstract=null), Reference(id=1325223705361658803, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAI HF, JIANG MQ, ZHAO YQ, et al. Three-dimensional cultured human umbilical cord mesenchymal stem cells attenuate pulmonary fibrosis by improving the balance of mitochondrial fusion and fission[J]. Stem Cells Transl Med,2024, 13(9): 912-926., articleTitle=null, refAbstract=null), Reference(id=1325223705449739188, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=LUO RX, WEI YQ, CHEN P, et al. Mesenchymal stem cells inhibit epithelial‐to‐mesenchymal transition by modulating the IRE1α branch of the endoplasmic reticulum stress response[J]. Stem Cells Int, 2023, 2023(1): 4483776., articleTitle=null, refAbstract=null), Reference(id=1325223705533625269, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=HASSAN N, ELBYOUME MN, TAHA MA, et al.Combinational therapy of mesenchymal stem cells and metformin in bleomycin-induced idiopathic pulmonary fibrosis in rat model[J]. Appl Biochem Biotechnol, 2025,197(8): 5511-5534., articleTitle=null, refAbstract=null), Reference(id=1325223705604928438, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=CHAKRABORTY A, WANG C, HODGSON-GARMS M,et al. Induced pluripotent stem cell-derived mesenchymal stem cells reverse bleomycin-induced pulmonary fibrosis and related lung stiffness[J]. Biomed Pharmacother, 2024, 178:117259., articleTitle=null, refAbstract=null), Reference(id=1325223705697203127, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG HT, ZHU Q, JI YX, et al. hucMSCs treatment prevents pulmonary fibrosis by reducing circANKRD42-YAP1-mediated mechanical stiffness[J]. Aging(Albany NY),2023, 15(12): 5514-5534., articleTitle=null, refAbstract=null), Reference(id=1325223705793672120, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAO J, JIANG Q, XU C, et al. MiR-26a-5p from HucMSC-derived extracellular vesicles inhibits epithelial mesenchymal transition by targeting Adam17 in silica-induced lung fibrosis[J]. Ecotoxicol Environ Saf, 2023, 257: 114950., articleTitle=null, refAbstract=null), Reference(id=1325223705923695545, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=NATALIYA B, MIKHAIL A, VLADIMIR P, et al.Mesenchymal stromal cells facilitate resolution of pulmonary fibrosis by miR-29c and miR-129 intercellular transfer[J].Exp Mol Med, 2023, 55(7): 1399-1412., articleTitle=null, refAbstract=null), Reference(id=1325223706083079098, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU Q, BI YK, SONG SL, et al. Exosomal miR-17-5p from human embryonic stem cells prevents pulmonary fibrosis by targeting thrombospondin-2[J]. Stem Cell Res Ther, 2023,14(1): 234., articleTitle=null, refAbstract=null), Reference(id=1325223706229879739, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=HAO XH, LI PY, WANG YD, et al. Mesenchymal stem cell-exosomal miR-99a attenuate silica-induced lung fibrosis by inhibiting pulmonary fibroblast transdifferentiation[J]. Int J Mol Sci, 2024, 25(23): 12626., articleTitle=null, refAbstract=null), Reference(id=1325223706338931644, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=LUO YK, ZHOU S, ZHANG XJ, et al. The role of the microbiota and metabolites in the treatment of pulmonary fibrosis with UC-MSCs: integrating fecal metabolomics and 16S rDNA analysis[J]. PLoS one, 2025, 20(1): e0313989., articleTitle=null, refAbstract=null), Reference(id=1325223706464760765, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=LI RQ, ZHANG HT, ZHANG JJ, et al. hucMSCs treatment ameliorated pulmonary fibrosis via downregulating the circFOXP1-HuR-EZH2/STAT1/FOXK1 autophagic axis[J].Stem Cells, 2023, 41(10): 928-943., articleTitle=null, refAbstract=null), Reference(id=1325223706628338622, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN HJ, LUO YL, ZHU YP, et al. Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats[J]. Front Pharmacol, 2023, 13:1070736., articleTitle=null, refAbstract=null)], funds=[Fund(id=1325223700269773714, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, awardId=23002400100, language=CN, fundingSource=上海市2023年度“科技创新行动计划”长三角科技创新共同体域项目:上海市先导物成药性研究与药物开发平台建设(23002400100), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1325223696805278570, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=1., ext=[AuthorCompanyExt(id=1325223696809472875, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696805278570, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1325223696817861484, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696805278570, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325223696897553261, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=2., ext=[AuthorCompanyExt(id=1325223696905941870, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696897553261, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Laboratory of Pharmacogenicity Research of Pioneers, Shanghai 200437, China), AuthorCompanyExt(id=1325223696910136175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696897553261, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.先导物成药性研究全国重点实验室,上海 200437)]), AuthorCompany(id=1325223696985633648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=3., ext=[AuthorCompanyExt(id=1325223696989827953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696985633648, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Professional and Technical Service Center for Biological Material Drug-Ability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1325223697002410866, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696985633648, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海市生物物质成药性评价技术服务平台,上海 200437)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.05.016, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.05.016, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2026.05.016, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2026.05.016, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1778342400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
间充质干细胞及细胞外囊泡:靶向肺纤维化的多维治疗机制及工程化突破
冯伟莉 1, 2, 3 , 刘莉 1, 2, 3 , 邓轶方 1, 2, 3, *
世界临床药物 | 综述评论 2026,47(5): 560-567
收起
收藏切换
世界临床药物 |综述评论 2026 , 47 (5) : 560 -567
间充质干细胞及细胞外囊泡:靶向肺纤维化的多维治疗机制及工程化突破
全屏
[Author(id=1325223697069519732, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223697207931768, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, authorId=1325223697069519732, language=EN, stringName=Weili FENG, firstName=Weili, middleName=null, lastName=FENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China
2.National Key Laboratory of Pharmacogenicity Research of Pioneers, Shanghai 200437, China
3.Shanghai Professional and Technical Service Center for Biological Material Drug-Ability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223697275040633, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, authorId=1325223697069519732, language=CN, stringName=冯伟莉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.中国医药工业研究总院,上海 201203
2.先导物成药性研究全国重点实验室,上海 200437
3.上海市生物物质成药性评价技术服务平台,上海 200437, bio={"content":"

冯伟莉,硕士研究生,研究方向:药物临床前药效学研究及机制研究。

"}, bioImg=null, bioContent=

冯伟莉,硕士研究生,研究方向:药物临床前药效学研究及机制研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223696805278570, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=1., ext=[AuthorCompanyExt(id=1325223696809472875, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696805278570, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1325223696817861484, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696805278570, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325223696897553261, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=2., ext=[AuthorCompanyExt(id=1325223696905941870, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696897553261, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Laboratory of Pharmacogenicity Research of Pioneers, Shanghai 200437, China), AuthorCompanyExt(id=1325223696910136175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696897553261, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.先导物成药性研究全国重点实验室,上海 200437)]), AuthorCompany(id=1325223696985633648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=3., ext=[AuthorCompanyExt(id=1325223696989827953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696985633648, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Professional and Technical Service Center for Biological Material Drug-Ability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1325223697002410866, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696985633648, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海市生物物质成药性评价技术服务平台,上海 200437)])]), Author(id=1325223697350538107, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223697447007103, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, authorId=1325223697350538107, language=EN, stringName=Li LIU, firstName=Li, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China
2.National Key Laboratory of Pharmacogenicity Research of Pioneers, Shanghai 200437, China
3.Shanghai Professional and Technical Service Center for Biological Material Drug-Ability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223697598002048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, authorId=1325223697350538107, language=CN, stringName=刘莉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.中国医药工业研究总院,上海 201203
2.先导物成药性研究全国重点实验室,上海 200437
3.上海市生物物质成药性评价技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223696805278570, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=1., ext=[AuthorCompanyExt(id=1325223696809472875, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696805278570, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1325223696817861484, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696805278570, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325223696897553261, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=2., ext=[AuthorCompanyExt(id=1325223696905941870, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696897553261, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Laboratory of Pharmacogenicity Research of Pioneers, Shanghai 200437, China), AuthorCompanyExt(id=1325223696910136175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696897553261, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.先导物成药性研究全国重点实验室,上海 200437)]), AuthorCompany(id=1325223696985633648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=3., ext=[AuthorCompanyExt(id=1325223696989827953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696985633648, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Professional and Technical Service Center for Biological Material Drug-Ability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1325223697002410866, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696985633648, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海市生物物质成药性评价技术服务平台,上海 200437)])]), Author(id=1325223697929352066, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223699074397062, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, authorId=1325223697929352066, language=EN, stringName=Yifang DENG, firstName=Yifang, middleName=null, lastName=DENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, *, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China
2.National Key Laboratory of Pharmacogenicity Research of Pioneers, Shanghai 200437, China
3.Shanghai Professional and Technical Service Center for Biological Material Drug-Ability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223699187643271, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, authorId=1325223697929352066, language=CN, stringName=邓轶方, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, *, address=1.中国医药工业研究总院,上海 201203
2.先导物成药性研究全国重点实验室,上海 200437
3.上海市生物物质成药性评价技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223696805278570, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=1., ext=[AuthorCompanyExt(id=1325223696809472875, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696805278570, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1325223696817861484, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696805278570, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1325223696897553261, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=2., ext=[AuthorCompanyExt(id=1325223696905941870, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696897553261, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Key Laboratory of Pharmacogenicity Research of Pioneers, Shanghai 200437, China), AuthorCompanyExt(id=1325223696910136175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696897553261, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.先导物成药性研究全国重点实验室,上海 200437)]), AuthorCompany(id=1325223696985633648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, xref=3., ext=[AuthorCompanyExt(id=1325223696989827953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696985633648, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Professional and Technical Service Center for Biological Material Drug-Ability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1325223697002410866, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223695517627239, companyId=1325223696985633648, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海市生物物质成药性评价技术服务平台,上海 200437)])])]
冯伟莉1, 2, 3, 刘莉1, 2, 3, 邓轶方1, 2, 3, *
作者信息
  • 1.中国医药工业研究总院,上海 201203
  • 2.先导物成药性研究全国重点实验室,上海 200437
  • 3.上海市生物物质成药性评价技术服务平台,上海 200437
通讯作者:
邓轶方,副研究员,硕士生导师,研究方向:药物研发、成药性评价、临床前药效学研究及机制研究。
作者简介:

冯伟莉,硕士研究生,研究方向:药物临床前药效学研究及机制研究。

Mesenchymal stem cells and extracellular vesicles: multidimensional therapeutic mechanisms and engineered breakthroughs targeting pulmonary fibrosis
Weili FENG1, 2, 3, Li LIU1, 2, 3, Yifang DENG1, 2, 3, *
Affiliations
  • 1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China
  • 2.National Key Laboratory of Pharmacogenicity Research of Pioneers, Shanghai 200437, China
  • 3.Shanghai Professional and Technical Service Center for Biological Material Drug-Ability Evaluation, Shanghai 200437, China
出版时间: 2026-05-10 doi: 10.13683/j.wph.2026.05.016
文章导航
收藏切换

肺纤维化是一种由环境暴露及感染等多因素诱发的慢性进行性间质性肺病,其核心病理特征表现为细胞外基质异常沉积及肌成纤维细胞过度活化。现有治疗药物因靶向性不足且无法逆转纤维化进程,故疗效有限。近年来,多能间充质干细胞及其分泌的细胞外囊泡(尤其是外泌体)凭借其独特的组织修复及免疫调节功能,在肺纤维化治疗领域展现出突破性潜力。该文系统阐述间充质干细胞及其细胞外囊泡(外泌体)的多维抗纤维化机制,同时深入探讨工程化修饰策略(如基因修饰、新型载体和递送系统以及联合干预)对疗效的提升作用,并分析从基础研究向临床转化面临的挑战,以期为新型抗纤维化药物的研究及间充质干细胞的临床应用提供理论依据。

间充质干细胞  /  细胞外囊泡  /  外泌体  /  肺纤维化  /  工程化修饰

Pulmonary fibrosis is a chronic progressive interstitial lung disease induced by multiple factors such as environmental exposure, infections. Its core pathological features are abnormal extracellular matrix deposition and myofibroblast over-activation. The efficacy of currently available therapeutic agents is limited, as they lack sufficient targeting capacity and are unable to reverse the progression of fibrosis. In recent years, pluripotent mesenchymal stem cells(MSCs) and their secreted extracellular vesicles(especially exosomes) have shown breakthrough potential in the treatment of pulmonary fibrosis due to their unique tissue repair and immunomodulatory functions. This article systematically reviewed the multidimensional antifibrotic mechanisms of MSCs and their extracellular vesicles(exosomes), deeply explored the engineered modification strategies(such as gene modification, novel vectors and delivery systems, and combined interventions) in enhancing therapeutic efficacy, and analyzed the challenges of translating from basic research to the clinic,in order to provide theoretical basis for the research of new anti-fibrosis drugs and the clinical application of MSCs.

mesenchymal stem cells  /  extracellular vesicles  /  exosomes  /  pulmonary fibrosis  /  engineering modifications
冯伟莉, 刘莉, 邓轶方. 间充质干细胞及细胞外囊泡:靶向肺纤维化的多维治疗机制及工程化突破. 世界临床药物, 2026 , 47 (5) : 560 -567 . DOI: 10.13683/j.wph.2026.05.016
Weili FENG, Li LIU, Yifang DENG. Mesenchymal stem cells and extracellular vesicles: multidimensional therapeutic mechanisms and engineered breakthroughs targeting pulmonary fibrosis[J]. World Clinical Drug, 2026 , 47 (5) : 560 -567 . DOI: 10.13683/j.wph.2026.05.016
  • 上海市2023年度“科技创新行动计划”长三角科技创新共同体域项目:上海市先导物成药性研究与药物开发平台建设(23002400100)
参考文献 引证文献
排序方式:
[1]
JIANG MN, BU WX, WANG XH, et al. Pulmonary fibrosis:from mechanisms to therapies[J]. J Transl Med, 2025, 23(1):515.
[2]
HAO MJ, GUAN ZJ, ZHANG ZK, et al. Atractylodinol prevents pulmonary fibrosis through inhibiting TGF-β receptor 1 recycling by stabilizing vimentin[J]. Mol Ther,2023, 31(10): 3015-3033.
[3]
ClUA-FERRE L, SUAU R, VANO-SEGARRA I, et al.Therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles: a focus on inflammatory bowel disease[J]. Clin Transl Med, 2024, 14(11): e70075.
[4]
GOLMOHAMMADI M, SHEIKHHA MH, GANJI F, et al.Human fetal lung mesenchymal stem cells ameliorate lung injury in an animal model[J]. Sci Rep, 2025, 15(1): 6433.
[5]
ATTIA SH, SAADAWY SF, EL-MAHROKY SM, et al. Alleviation of pulmonary fibrosis by the dual PPAR agonist saroglitazar and breast milk mesenchymal stem cells via modulating TGF-β/SMAD pathway[J]. Naunyn Schmiedebergs Arch Pharmacol, 2024, 397(8): 5953-5974.
[6]
LIU JX, ZHAO LP, LI CS, et al. Mesenchymal stem cell treatment alleviates seawater drowning induced lung injury by inhibiting the TNF-α/Snail/EMT pathway[J]. J Thorac Dis, 2024, 16(11): 7836-7852.
[7]
XIE YY, YI Q, XU CW, et al. Identifying TNFSF4low-MSCs superiorly treating idiopathic pulmonary fibrosis through Tregs differentiation modulation[J]. Stem Cell Res Ther,2025, 16(1): 194.
[8]
DUAN R, HONG CG, WANG X, et al. Olfactory mucosa mesenchymal stem cells alleviate pulmonary fibrosis via the immunomodulation and reduction of inflammation[J]. Bio Med Central Pulm Med, 2024, 24(1): 14.
[9]
CHOI SM, MO Y, BANG JY, et al. Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis[J]. Respir Res, 2023, 24(1): 68.
[10]
LEE H, JEONG OY, PARK HJ, et al. Promising therapeutic effects of embryonic stem cells-origin mesenchymal stem cells in experimental pulmonary fibrosis models: Immunomodulatory and anti-apoptotic mechanisms[J].Immune Netw, 2023, 23(6): e45.
[11]
XU W, LI CK, YANG LS, et al. Immune response regulation by transduced mesenchymal stem cells with decorin gene on bleomycin-induced lung injury, fibrosis, and inflammation[J].Allergol Immunopathol(Madr), 2024, 52(4): 53-59.
[12]
LI M, LI J, WANG Y, et al. Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis[J]. Stem Cell Res Ther, 2024,15(1): 475.
[13]
HOU L, ZHU ZH, JIANG FY, et al. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles alleviated silica induced lung inflammation and fibrosis in mice via circPWWP2A/miR-223-3p/NLRP3 axis[J].Ecotoxicol Environ Saf, 2023, 251: 114537.
[14]
LIANG XP, LI YH, WU YL, et al. Human umbilical cord mesenchymal stem cell-derived microvesicles alleviate pulmonary fibrosis by inhibiting monocyte-macrophage migration through ERK1/2 signaling-mediated suppression of CCL2 expression[J]. Stem Cell Res Ther, 2025, 16(1):145.
[15]
GAO Y, LIU MF, LI Y, et al. Mesenchymal stem cells-extracellular vesicles alleviate pulmonary fibrosis by regulating immunomodulators[J]. World J Stem Cells, 2024,16(6): 670-689.
[16]
CHEN F, CHEN ZD, WU HT, et al. Mesenchymal stem cell-derived exosomes attenuate murine cytomegalovirus-infected pneumonia via NF-κB/NLRP3 signaling pathway[J].Viruses, 2024, 16(4): 619.
[17]
CHEN W, PENG J, TANG XY, et al. MSC-derived exosome ameliorates pulmonary fibrosis by modulating NOD 1/NLRP3-mediated epithelial-mesenchymal transition and inflammation[J]. Heliyon, 2025, 11(2): e41436.
[18]
ELLIOT SJ, ANDERSON-TERHUNE D, ROOS B,et al. Ratio of miRNA-29 to miRNA-199 expression coordinates mesenchymal stem cell repair of bleomycin-induced pulmonary injury[J]. Mol Ther Nucl Acids, 2025,doi:10.1016/j.omtn.2025.102461.
[19]
ZHAO X, WU JY, YUAN RY, et al. Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis[J]. Sci Rep, 2021,doi:10.21203/rs.3.rs-977764/v1.
[20]
ZHI YF, SHU MH, TANG PS, et al. Overexpression of decorin optimizes the treatment efficacy of umbilical cord mesenchymal stem cells in bleomycin-induced pulmonary fibrosis in rats[J]. Stem Cells Int, 2025, 2025(1): 6324980.
[21]
ZHOU W, WANG J, DING L, et al. Autophagy inhibition enhances antifibrotic potential of placental mesenchymal stem cells of fetal origin via regulating TGF-β1 mediated protein degradation of HGF[J]. Sci Rep, 2025, 15(1): 13805.
[22]
OUJI-SAGESHIMA N, HIYAMA A, KUMAMOTO M, et al.Adipose-derived mesenchymal stem cells(ADSCs) have antifibrotic effects on lung fibroblasts from idiopathic pulmonary fibrosis(IPF) patients[J]. Cells, 2024, 13(24): 2050.
[23]
CHEN QH, ZHANG Y, GU X, et al. Microvesicles derived from mesenchymal stem cells inhibit acute respiratory distress syndrome-related pulmonary fibrosis in mouse partly through hepatocyte growth factor[J]. World J Stem Cells,2024, 16(8): 811-823.
[24]
ZHANG WY, WEN L, DU L, et al. S-RBD-modified and miR-486-5p-engineered exosomes derived from mesenchymal stem cells suppress ferroptosis and alleviate radiation-induced lung injury and long-term pulmonary fibrosis[J]. J Nanobiotechnol, 2024, 22(1): 662.
[25]
CAI LY, WANG J, YI X, et al. Nintedanib-loaded exosomes from adipose-derived stem cells inhibit pulmonary fibrosis induced by bleomycin[J]. Pediatr Res, 2024, 95(6): 1543-1552.
[26]
XIAO K, LIU C, WANG HM, et al. Umbilical cord mesenchymal stem cells overexpressing CXCR7 facilitate treatment of ARDS-associated pulmonary fibrosis via inhibition of Notch/Jag1 mediated by the Wnt/β-catenin pathway[J]. Biomed Pharmacothery, 2023, 165: 115124.
[27]
JIANG QY, NING FA, JIA QY, et al. MiR-148a-3p loaded human umbilical cord mesenchymal stem cell-derived extracellular vesicles alleviates silica-induced pulmonary fibrosis by inhibiting β-catenin signaling[J]. Int J Nanomedicine, 2025, 20: 4319-4336.
[28]
QIU HJ, ZHANG R, SI DZ, et al. Human umbilical cord-mesenchymal stem cells combined with low dosage nintedanib rather than using alone mitigates pulmonary fibrosis in mice[J]. Stem Cells Int, 2025, 2025(1): 9445735.
[29]
WANG YY, LIU C, WANG NX, et al. hAMSCs regulate EMT in the progression of experimental pulmonary fibrosis through delivering miR-181a-5p targeting TGFBR1[J]. Stem Cell Res Ther, 2025, 16(1): 2.
[30]
HAN MM, HE XY, TANG L, et al. Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice[J]. Sci Adv, 2023, 9(29): eadg5358.
[31]
CHU KA, YEH CC, HSU CH, et al. Reversal of pulmonary fibrosis: human umbilical mesenchymal stem cells from Wharton's jelly versus human-adipose-derived mesenchymal stem cells[J]. Int J Mol Sci, 2023, 24(8): 6948.
[32]
ZHAI HF, JIANG MQ, ZHAO YQ, et al. Three-dimensional cultured human umbilical cord mesenchymal stem cells attenuate pulmonary fibrosis by improving the balance of mitochondrial fusion and fission[J]. Stem Cells Transl Med,2024, 13(9): 912-926.
[33]
LUO RX, WEI YQ, CHEN P, et al. Mesenchymal stem cells inhibit epithelial‐to‐mesenchymal transition by modulating the IRE1α branch of the endoplasmic reticulum stress response[J]. Stem Cells Int, 2023, 2023(1): 4483776.
[34]
HASSAN N, ELBYOUME MN, TAHA MA, et al.Combinational therapy of mesenchymal stem cells and metformin in bleomycin-induced idiopathic pulmonary fibrosis in rat model[J]. Appl Biochem Biotechnol, 2025,197(8): 5511-5534.
[35]
CHAKRABORTY A, WANG C, HODGSON-GARMS M,et al. Induced pluripotent stem cell-derived mesenchymal stem cells reverse bleomycin-induced pulmonary fibrosis and related lung stiffness[J]. Biomed Pharmacother, 2024, 178:117259.
[36]
ZHANG HT, ZHU Q, JI YX, et al. hucMSCs treatment prevents pulmonary fibrosis by reducing circANKRD42-YAP1-mediated mechanical stiffness[J]. Aging(Albany NY),2023, 15(12): 5514-5534.
[37]
ZHAO J, JIANG Q, XU C, et al. MiR-26a-5p from HucMSC-derived extracellular vesicles inhibits epithelial mesenchymal transition by targeting Adam17 in silica-induced lung fibrosis[J]. Ecotoxicol Environ Saf, 2023, 257: 114950.
[38]
NATALIYA B, MIKHAIL A, VLADIMIR P, et al.Mesenchymal stromal cells facilitate resolution of pulmonary fibrosis by miR-29c and miR-129 intercellular transfer[J].Exp Mol Med, 2023, 55(7): 1399-1412.
[39]
LIU Q, BI YK, SONG SL, et al. Exosomal miR-17-5p from human embryonic stem cells prevents pulmonary fibrosis by targeting thrombospondin-2[J]. Stem Cell Res Ther, 2023,14(1): 234.
[40]
HAO XH, LI PY, WANG YD, et al. Mesenchymal stem cell-exosomal miR-99a attenuate silica-induced lung fibrosis by inhibiting pulmonary fibroblast transdifferentiation[J]. Int J Mol Sci, 2024, 25(23): 12626.
[41]
LUO YK, ZHOU S, ZHANG XJ, et al. The role of the microbiota and metabolites in the treatment of pulmonary fibrosis with UC-MSCs: integrating fecal metabolomics and 16S rDNA analysis[J]. PLoS one, 2025, 20(1): e0313989.
[42]
LI RQ, ZHANG HT, ZHANG JJ, et al. hucMSCs treatment ameliorated pulmonary fibrosis via downregulating the circFOXP1-HuR-EZH2/STAT1/FOXK1 autophagic axis[J].Stem Cells, 2023, 41(10): 928-943.
[43]
CHEN HJ, LUO YL, ZHU YP, et al. Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats[J]. Front Pharmacol, 2023, 13:1070736.
2026年第47卷第5期
62
12
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2026.05.016
  • 接收时间:2025-09-02
  • 首发时间:2026-11-05
  • 出版时间:2026-05-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-09-02
基金
上海市2023年度“科技创新行动计划”长三角科技创新共同体域项目:上海市先导物成药性研究与药物开发平台建设(23002400100)
作者信息
    1.中国医药工业研究总院,上海 201203
    2.先导物成药性研究全国重点实验室,上海 200437
    3.上海市生物物质成药性评价技术服务平台,上海 200437

通讯作者:

邓轶方,副研究员,硕士生导师,研究方向:药物研发、成药性评价、临床前药效学研究及机制研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.05.016
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏